Solved

Which Statement Regarding Intravenous Ketamine as a Treatment for Depression

Question 10

Multiple Choice

Which statement regarding intravenous ketamine as a treatment for depression is false?


A) The dose required to reduce depression symptoms is much higher than that needed for anesthesia.
B) It reduces symptoms in 65-70% of patients who are resistant to other treatments.
C) Its effects typically last 1-3 weeks.
D) In addition to blocking NMDA type glutamate receptors, it enhances AMPA receptor response to glutamate.

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions